A Double-Blind Randomized, Parallel-Group, Multicenter Clinical Study to Compare the Efficacy and Tolerability of Tiotropium Bromide Alone vs. the Co-Administration of Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD
Latest Information Update: 05 May 2022
Price :
$35 *
At a glance
- Drugs Formoterol (Primary) ; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 02 Feb 2007 Status change from initiated to completed.
- 30 Oct 2005 New trial record.